~~<i id='D14F7D81CF'><strike id='D14F7D81CF'><tt id='D14F7D81CF'><pre id='D14F7D81CF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：leisure time 2025-09-04 06:02:11 - browse：51866

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

hotspot

focus

entertainment

Onthisweek’s“ReadoutLOUD,”we’reliveinSanFranciscoatSTAT’sBreakthroughSummitWest.AIisabigthemethisyea

WSS

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Bird flu: Don't repeat Covid's 'health versus the economy' framing

As AI regulations shape up, health tech startups beg for clarity

When prostate cancer spreads, where it goes matters

Data integrity in scientific journals requires "effort" by publishers, institutions

WATCH: Why do our ears pop?

focus

comprehensive

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Drug repurposing or repositioning? The language matters

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Drug repurposing or repositioning? The language matters

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Medicare details structure of new drug price negotiation program

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A new drug could help frostbite victims avoid its ravages

hotspot

MD Anderson's Padmanee Sharma responds to research credit suit

In 'major milestone,' FDA approves first cell therapy for solid tumors

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

focus

entertainment

entertainment